Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improving Accessibility in Rheumatology Conferences: A Multidisciplinary Perspective.

The Journal of rheumatology·2026

Same author

Diagnostic and prognostic utility of complete blood count-derived ratios in giant cell arteritis: a retrospective fast-track clinic cohort study.

Rheumatology international·2025

Same author

Patient characteristics and outcomes of emergency visits in psoriatic arthritis: results from the U.S. Nationwide Emergency Department Sample.

Clinical rheumatology·2025

Same author

Delays in Tocilizumab Therapy for Patients With Giant Cell Arteritis in the United States.

The Journal of rheumatology·2025

Same author

Characteristics associated with anterior ischemic optic neuropathy (AION) in giant cell arteritis (GCA).

Clinical rheumatology·2024

Same author

The Common Carotid Artery in the Ultrasound Evaluation of Giant Cell Arteritis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2024

Search research articles

Related Experiment Video

Updated: Mar 20, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.

Alison M Bays¹, Gregory Gardner²

¹Division of Rheumatology, Department of Internal Medicine, Harborview Medical Center, 325 9th Avenue, Box 356428, Seattle, WA 98104, USA.

The Medical Clinics of North America

|May 29, 2016

Summary

This summary is machine-generated.

Disease-modifying antirheumatic drugs (DMARDs), steroids, and biologic agents help manage autoimmune conditions like lupus and rheumatoid arthritis. Careful patient monitoring for infections, bone health, and vaccinations is crucial during treatment.

Keywords:

Autoimmune Biologic agents Disease-modifying antirheumatic drugs (DMARDs)Gout Immunosuppression Rheumatology

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model

Published on: October 30, 2019

Related Experiment Videos

Last Updated: Mar 20, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model

Published on: October 30, 2019

Area of Science:

Rheumatology
Immunology
Pharmacology

Background:

Autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus require long-term management.
Disease-modifying antirheumatic drugs (DMARDs) are a cornerstone of therapy to reduce disease activity.
Biologic agents and corticosteroids are also utilized, often in combination with DMARDs.

Purpose of the Study:

To review the current landscape of treatments for inflammatory autoimmune conditions.
To highlight the importance of comprehensive management strategies for patients on DMARDs, steroids, and biologics.

Main Methods:

Literature review of current therapeutic options for autoimmune diseases.
Analysis of treatment guidelines and clinical practice considerations.
Synthesis of information regarding the safety and efficacy of immunomodulatory therapies.

Main Results:

DMARDs are essential for controlling disease activity and achieving remission.
Corticosteroids should be used judiciously at the lowest effective dose.
A wide array of biologic agents are available for various autoimmune conditions.

Conclusions:

Prescribing and managing DMARDs, steroids, and biologic agents requires careful consideration.
Proactive screening for infectious diseases, vaccination status, bone health, and regular laboratory monitoring are critical components of patient care.
Integrated management strategies are vital for optimizing outcomes in patients with autoimmune diseases.